Patient Charged After Alleged Fire Attack in Sydney Spinal Ward
A 48-year-old patient has been charged with two counts of attempted murder after an alleged accelerant attack inside Sydney's Prince of Wales Hospital in Randwick.
Police allege Raymond James Dungay, himself a patient on the spinal ward, poured an accelerant over three other patients on Tuesday night and then set fire to one of them. An accelerant is a substance that helps fire catch and spread. Emergency services were called to the hospital at about 10.45pm, according to reporting detailed by The Guardian. Dungay had been admitted to that ward, as reported by The Age.
The three people were a 54-year-old man, a 63-year-old man and a 64-year-old woman. The 54-year-old was identified as spinal patient Randovan Banic. Police allege Dungay ignited the accelerant on Banic. Staff intervened and extinguished the fire. Banic sustained minor burns and was observed as a precaution. The other two patients were treated for minor injuries and remained in stable condition.
Dungay was also charged with two counts of intent to cause grievous bodily harm, a legal term for serious injury, and with common assault. He was expected to appear at a bail hearing on Thursday, where a court decides custody before trial. The South Eastern Sydney Local Health District said staff responded quickly and notified NSW police. It said there was no ongoing risk to patients and staff.
The broader context here is the setting. A spinal ward cares for people with limited mobility who rely on staff to move or evacuate, like passengers who need crew help in an emergency. Emergency departments deal with agitation every day. A recovery ward is supposed to feel controlled. When that breaks, confidence among patients, families and staff can drop fast and takes clear safety updates to rebuild.
In my view, the legal test will be intent. Attempted murder and intent to cause serious injury require prosecutors to prove what was poured, how ignition happened, and what Dungay intended. The bail hearing will weigh risk, health and custody, while hospital reviewers will ask how an accelerant entered a clinical space.
